Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glyburide for Cerebral Edema Prophylaxis in SRS
NCT02460874Phase 2Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Aug 2017
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glibenclamide in cerebral edema, sponsored by University of Alabama at Birmingham. Started Aug 2017; status: terminated.
02
Drugs
glibenclamide
03
Conditions
cerebral edema
Beyond the preview
Go deeper on NCT02460874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460874.